Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
US7250419B2 · kind B2 · utility
6Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2005 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | Sep 21, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.